BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 151 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $256,000 | -31.2% | 146,064 | +5.9% | 0.00% | – |
Q3 2016 | $372,000 | +28.3% | 137,896 | +12.1% | 0.00% | – |
Q2 2016 | $290,000 | -92.5% | 123,009 | -89.8% | 0.00% | -100.0% |
Q1 2016 | $3,884,000 | -35.4% | 1,202,459 | -4.1% | 0.00% | 0.0% |
Q4 2015 | $6,009,000 | -10.1% | 1,254,503 | +4.4% | 0.00% | -50.0% |
Q3 2015 | $6,683,000 | -29.4% | 1,201,893 | +1.1% | 0.00% | 0.0% |
Q2 2015 | $9,462,000 | -23.4% | 1,188,695 | +1.1% | 0.00% | -33.3% |
Q1 2015 | $12,349,000 | -12.2% | 1,176,073 | +0.5% | 0.00% | 0.0% |
Q4 2014 | $14,060,000 | -17.5% | 1,169,715 | +17.3% | 0.00% | -40.0% |
Q3 2014 | $17,047,000 | +36.4% | 997,499 | -3.7% | 0.01% | +25.0% |
Q2 2014 | $12,501,000 | +42.0% | 1,035,716 | -0.7% | 0.00% | +33.3% |
Q1 2014 | $8,804,000 | +84.7% | 1,043,119 | +28.9% | 0.00% | +200.0% |
Q4 2013 | $4,767,000 | +3.8% | 809,317 | -4.4% | 0.00% | -50.0% |
Q3 2013 | $4,594,000 | +51.3% | 846,132 | +13.1% | 0.00% | +100.0% |
Q2 2013 | $3,036,000 | – | 747,832 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |